NKE
NIKE, Inc.
NKE's fundamentals are mixed, but it looks cheap: trading at 18x earnings, below its usual 33x. Analysts expect earnings to hold roughly steady, though they disagree widely on how much.
SRI
Stoneridge, Inc.
There isn't enough reported data to score SRI yet.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
SRI Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Under pressure | |
| Strong |
SRI's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE's PE is in its cheap range at 18x. On analysts' estimates for next year's earnings, today's price would be 30x, in its fair range.
SRI PE Valuation
SRI has no meaningful PE right now: it lost money over the past year.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
SRI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Stable | |
| -- | |
| Limited | |
| -- |
Analysts expect SRI's earnings to decline, with its revenue and profitability holding steady.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE has the edge over SRI on earnings quality, reporting a profit while its opponent remains loss making.
SRI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$4.76 | -$3.60 |
| Q2 2026 | -$4.29 | -$3.21 |
| Q1 2026 | -$4.44 | -$3.80 |
| Q4 2025 | -$3.70 | -$3.10 |
| Q3 2025 | -$1.16 | -$0.89 |
| Q2 2025 | -$1.08 | -1643% |
| Q1 2025 | -$0.64 | -$0.50 |
| Q4 2024 | -$0.60 | -$0.41 |
SRI lost $4.76 per share over the past year, a bigger loss than the year before.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE has the edge over SRI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE has the edge over SRI on profitability, with a higher operating margin.
SRI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $155.8M | -26% |
| Q2 2026 | $181.4M | -20% |
| Q1 2026 | $160.8M | -26% |
| Q4 2025 | $205.2M | -6% |
| Q3 2025 | $210.3M | -1.7% |
| Q2 2025 | $228M | -3.8% |
| Q1 2025 | $217.9M | -8.9% |
| Q4 2024 | $218.2M | -4.9% |
SRI's revenue has slid since its 2023 peak: $156M last quarter, down 26% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -15% | -14 points |
| Q2 2026 | -0.7% | +0.5 points |
| Q1 2026 | -5.6% | -4.1 points |
| Q4 2025 | -14% | -12 points |
| Q3 2025 | -1.6% | -1.7 points |
| Q2 2025 | -1.1% | -2.6 points |
| Q1 2025 | -1.5% | -1.6 points |
| Q4 2024 | -2% | -4.7 points |
SRI's operating margin was −15% last quarter, down 14 points from the same quarter a year ago, near the bottom of its range since 2019.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE has the edge over SRI on cash generation, producing positive trailing cash flow while its opponent burns cash.
SRI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$236K | +$2.5M |
| Q2 2026 | $7.7M | +4.5% |
| Q1 2026 | -$12.3M | -356% |
| Q4 2025 | $2.6M | -81% |
| Q3 2025 | -$2.7M | -158% |
| Q2 2025 | $7.4M | +385% |
| Q1 2025 | $4.8M | +46% |
| Q4 2024 | $14M | +1897% |
SRI's free cash flow was −$2M over the past year, against $24M the year before.
NKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.4% | +5.2M shares |
| 3 years | -3.8% | -59.1M shares |
| 5 years | -8.4% | -135M shares |
| Available history | -6.9% | -110M shares |
NKE has the edge over SRI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $20M |
| Q3 2025 | $126M |
| Q2 2025 | $199M |
| Q1 2025 | $506M |
| Q4 2024 | $1.1B |
NKE has spent almost nothing on buybacks in the past year.
SRI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +143K shares |
| 1 year | +1.9% | +528K shares |
| 3 years | +2.4% | +653K shares |
| 5 years | +4.6% | +1.2M shares |
| Available history | +0.4% | +117K shares |
SRI has 28M diluted shares, up 1.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | $5M |
| Q4 2019 | — |
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE's net debt is less than a year of its operating earnings (EBITDA).
SRI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | -2.8x | Net Cash |
| Q2 2025 | 5.2x | High |
| Q1 2025 | 4.3x | High |
| Q4 2024 | -2.1x | Net Cash |
| Q3 2024 | -1.2x | Net Cash |
| Q2 2024 | -0.8x | Net Cash |
| Q1 2024 | -0.9x | Net Cash |
| Q4 2023 | -0.8x | Net Cash |
SRI has more cash than debt.
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
SRI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.1 | Neutral |
| Stochastic | 9.0 | Oversold |
SRI's weekly RSI is 33 (neutral) and its Stochastic is 9 (oversold).
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x.
SRI PE vs Consumer Cyclical Sector
| Metric | SRI | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
SRI has no meaningful PE right now: it lost money over the past year.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has the edge over SRI on trend strength, trading above more of its moving averages.
SRI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.92 | 14% below |
| 20 week MA | $6.68 | 24% below |
| 50 week MA | $6.70 | 24% below |
| 100 week MA | $6.37 | 20% below |
| 200 week MA | $11.5 | 56% below |
SRI is in a downtrend: it's below all five of its weekly moving averages, and 56% below its 200-week average.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has finished four years in a row lower, and it's down 38% so far in 2026.
SRI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.7 | $29.6 | -0.1% |
| 2021 | $29.6 | $18.7 | -37% |
| 2022 | $18.7 | $21.3 | +14% |
| 2023 | $21.3 | $19.6 | -8% |
| 2024 | $19.6 | $6.21 | -68% |
| 2025 | $6.21 | $5.69 | -8.4% |
| 2026 YTD | $5.69 | $5.09 | -11% |
SRI has the edge over NKE on returns for 2026, with the stronger performance.